Fate Therapeutics Appoints Jamie Harrell as Chief Commercial Officer
Position
Chief Commercial Officer
Company
Fate Therapeutics
Description
Fate Therapeutics has announced the appointment of Jamie Harrell to its executive leadership team as Chief Commercial Officer, effective October 12, 2026. Mr. Harrell will lead the commercial and market development strategy across the Company's autoimmunity and oncology programs.
Quick answer
Fate Therapeutics Appoints Jamie Harrell as Chief Commercial Officer (October 12, 2026). Fate Therapeutics is based in San Diego, California, United States.
- Who is the new Chief Commercial Officer at Fate Therapeutics?
- Fate Therapeutics named Jamie Harrell Chief Commercial Officer, announced October 12, 2026.
- What did Fate Therapeutics announce on October 12, 2026?
- Fate Therapeutics has announced the appointment of Jamie Harrell to its executive leadership team as Chief Commercial Officer, effective October 12, 2026. Mr. Harrell will lead the commercial and market development strategy across the Company's autoimmunity and oncology programs.
- What does Fate Therapeutics do?
- Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing first-in-class induced pluripotent stem cell (iPSC)-derived cellular immunotherapies.
- Where is Fate Therapeutics based?
- Fate Therapeutics is based in San Diego, California, United States.
- Which similar companies made leadership changes around the same time?
- Harmony Biosciences (October 12, 2026), Verastem Oncology (October 14, 2026), Jazz Pharmaceuticals plc (October 9, 2026) and TORL BioTherapeutics (October 16, 2026) also announced leadership changes within 45 days of Fate Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Harmony Biosciences Appoints Peter Anastasiou as Chief Executive Officer (October 12, 2026)
- Michael Bailey Appointed as President and CEO of Verastem, Inc. (October 14, 2026)
- Jazz Pharmaceuticals Announces Transition in Leadership (October 9, 2026)
- TORL BioTherapeutics Appoints Sandip Kapadia as Chief Financial Officer and Eric Sievers, M.D. as Chief Medical Officer (October 16, 2026)
- Transcenta Therapeutics Appoints Jennie Ma as Chief Financial Officer (October 19, 2026)
- Tempest Therapeutics Appoints John Frederick as Class III Director (October 19, 2026)
Who to call at Fate Therapeutics, and when
A new leader at Fate Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Fate Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Fate Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Fate Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Fate Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Fate Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.